𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study

✍ Scribed by M. Graf; D. Ecker; R. Horowski; B. Kramer; P. Riederer; M. Gerlach; C. Hager; A. C. Ludolph; B. Kramer; D. Ecker; G. Becker; J. Osterhage; W. H. Jost; B. Schrank; C. Stein; P. Kostopulos; S. Lubik; K. Wekwerth; R. Dengler; M. Troeger; A. Wuerz; A. Hoge; C. Schrader; N. Schimke; K. Krampfl; S. Petri; S. Zierz; K. Eger; S. Neudecker; K. Traufeller; M. Sievert; B. Neundörfer; M. Hecht

Publisher
Springer
Year
2004
Tongue
English
Weight
140 KB
Volume
112
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
✍ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to

Efficacy of selegiline add on therapy to
Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study
✍ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI‐B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of